• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶B、K和L对AL淀粉样蛋白及AL淀粉样沉积物的切割作用

Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L.

作者信息

Bohne Silvia, Sletten Knut, Menard Robert, Bühling Frank, Vöckler Steffi, Wrenger Eike, Roessner Albert, Röcken Christoph

机构信息

Institute of Pathology, Otto-von-Guericke-University of Magdeburg, Leipziger Strasse 44, D-39120 Magdeburg, Germany.

出版信息

J Pathol. 2004 May;203(1):528-37. doi: 10.1002/path.1553.

DOI:10.1002/path.1553
PMID:15095475
Abstract

Cathepsin (Cath) B, CathK and CathL are cysteine proteases that participate in the lysosomal protein degradation system and are expressed in macrophages, epithelioid cells, and multinucleated histiocytic giant cells (MGCs). Both macrophages and MGCs are commonly found adjacent to immunoglobulin light chain-associated (AL) amyloid deposits, which raised the question of whether cysteine proteases are able to cleave AL amyloid proteins and AL amyloid deposits. The present study has investigated whether recombinant human CathB, CathK, and CathL are able to degrade AL(VlambdaVI) amyloid proteins and AL amyloid deposits. Using immunohistochemistry, CathB, CathK, and CathL were found adjacent to AL amyloid deposits. In vitro degradation experiments using purified AL amyloid proteins showed that CathB, CathK, and CathL degrade AL(VlambdaVI) amyloid proteins. Furthermore, using unfixed tissue sections from an amyloidotic spleen as an in vitro model for extracellular proteolysis of intact amyloid deposits, it was demonstrated that all three cysteine proteases are also capable of degrading AL amyloid in situ. This is the first study to show that cysteine proteases are able to cleave AL amyloid proteins. However, the efficiency with which proteolysis occurs depends on the concentration of active protease recruited at the sites of amyloid deposition, and possibly on the structure of the AL amyloid proteins.

摘要

组织蛋白酶(Cath)B、CathK和CathL是参与溶酶体蛋白降解系统的半胱氨酸蛋白酶,在巨噬细胞、上皮样细胞和多核组织细胞性巨细胞(MGCs)中表达。巨噬细胞和MGCs通常都存在于免疫球蛋白轻链相关(AL)淀粉样沉积物附近,这就引发了一个问题,即半胱氨酸蛋白酶是否能够裂解AL淀粉样蛋白和AL淀粉样沉积物。本研究调查了重组人CathB、CathK和CathL是否能够降解AL(VlambdaVI)淀粉样蛋白和AL淀粉样沉积物。通过免疫组织化学方法,发现CathB、CathK和CathL存在于AL淀粉样沉积物附近。使用纯化的AL淀粉样蛋白进行的体外降解实验表明,CathB、CathK和CathL可降解AL(VlambdaVI)淀粉样蛋白。此外,使用来自淀粉样变性脾脏的未固定组织切片作为完整淀粉样沉积物细胞外蛋白水解的体外模型,结果表明所有这三种半胱氨酸蛋白酶也能够在原位降解AL淀粉样蛋白。这是第一项表明半胱氨酸蛋白酶能够裂解AL淀粉样蛋白的研究。然而,蛋白水解发生的效率取决于在淀粉样沉积部位募集的活性蛋白酶的浓度,并且可能还取决于AL淀粉样蛋白的结构。

相似文献

1
Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L.组织蛋白酶B、K和L对AL淀粉样蛋白及AL淀粉样沉积物的切割作用
J Pathol. 2004 May;203(1):528-37. doi: 10.1002/path.1553.
2
Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis.组织蛋白酶的蛋白酶活性调节脑外淀粉样变性中的淀粉样蛋白负荷。
J Pathol. 2006 Dec;210(4):478-87. doi: 10.1002/path.2076.
3
Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.半胱氨酸蛋白酶对血清淀粉样蛋白A和AA淀粉样蛋白的蛋白水解作用:组织蛋白酶B产生AA淀粉样蛋白,而组织蛋白酶L可能会阻止其形成。
Ann Rheum Dis. 2005 Jun;64(6):808-15. doi: 10.1136/ard.2004.030429.
4
A putative role for cathepsin K in degradation of AA and AL amyloidosis.组织蛋白酶K在AA型和AL型淀粉样变性降解中的假定作用。
Am J Pathol. 2001 Mar;158(3):1029-38. doi: 10.1016/S0002-9440(10)64050-3.
5
Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.组织蛋白酶K信使核糖核酸在人类骨关节炎滑膜组织中巨细胞及其前体细胞中的表达
Arthritis Rheum. 1999 Aug;42(8):1588-93. doi: 10.1002/1529-0131(199908)42:8<1588::AID-ANR4>3.0.CO;2-S.
6
Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.淀粉样前体蛋白向β淀粉样肽的溶酶体加工过程:组织蛋白酶S的独特作用。
Biochem J. 1995 Oct 1;311 ( Pt 1)(Pt 1):299-305. doi: 10.1042/bj3110299.
7
Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.半胱氨酸蛋白酶组织蛋白酶L对尿激酶型纤溶酶原激活剂(pro-uPA)的酶原形式的有效激活。
FEBS Lett. 1992 Feb 3;297(1-2):112-8. doi: 10.1016/0014-5793(92)80339-i.
8
Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor.组织蛋白酶B、L和S可切割并使分泌型白细胞蛋白酶抑制剂失活。
J Biol Chem. 2001 Sep 7;276(36):33345-52. doi: 10.1074/jbc.M103220200. Epub 2001 Jul 2.
9
Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.人重组前二肽基肽酶I(组织蛋白酶C)可被组织蛋白酶L和S激活,但不能通过自身催化加工激活。
Biochemistry. 2001 Feb 13;40(6):1671-8. doi: 10.1021/bi001693z.
10
Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L.用于研究人组织蛋白酶K和L假定血管活性特性的激肽原衍生肽。
Eur J Biochem. 2003 Jan;270(1):171-8. doi: 10.1046/j.1432-1033.2003.03382.x.

引用本文的文献

1
The molecular landscape of AL amyloidosis.AL淀粉样变性的分子图谱。
Br J Haematol. 2025 May;206(5):1297-1311. doi: 10.1111/bjh.20070. Epub 2025 Apr 11.
2
Cathepsin B prevents cell death by fragmentation and destruction of pathological amyloid fibrils.组织蛋白酶B通过分解和破坏病理性淀粉样原纤维来防止细胞死亡。
Cell Death Discov. 2025 Feb 15;11(1):61. doi: 10.1038/s41420-025-02343-w.
3
Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.AL 淀粉样变性发病机制与治疗策略的分子机制
Int J Mol Sci. 2022 Jun 6;23(11):6336. doi: 10.3390/ijms23116336.
4
Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.淀粉样轻链中的蛋白酶敏感区域:器官间普遍存在的片段化模式对聚集的启示。
FEBS J. 2022 Jan;289(2):494-506. doi: 10.1111/febs.16182. Epub 2021 Sep 15.
5
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.心脏轻链淀粉样变中轻链片段化位点的质谱分析:对蛋白水解时间的深入了解。
J Biol Chem. 2020 Dec 4;295(49):16572-16584. doi: 10.1074/jbc.RA120.013461. Epub 2020 Sep 20.
6
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.质谱流式细胞术剖析了常见副蛋白血症初诊时及一线治疗后的免疫肿瘤微环境中 T 细胞的异质性。
Blood Cancer J. 2019 Aug 28;9(9):72. doi: 10.1038/s41408-019-0234-4.
7
Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.抗 AA 淀粉样蛋白特异性单克隆抗体的制备和鉴定。
Front Immunol. 2011 Aug 8;2:32. doi: 10.3389/fimmu.2011.00032. eCollection 2011.
8
Multiple myeloma-associated iliopsoas muscular amyloidoma first presenting with bilateral femoral nerve entrapment.多发性骨髓瘤相关性髂腰肌肌淀粉样变性瘤首发表现为双侧股神经嵌压。
Int J Hematol. 2012 Jun;95(6):716-20. doi: 10.1007/s12185-012-1063-4. Epub 2012 Apr 7.
9
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.载脂蛋白 A-I L75P 淀粉样变体对 HDL 亚群的影响。
Clin Chim Acta. 2011 Jun 11;412(13-14):1262-5. doi: 10.1016/j.cca.2011.03.027. Epub 2011 Mar 31.
10
[Amyloidosis in liver biopsies].[肝脏活检中的淀粉样变性]
Pathologe. 2009 May;30(3):240-5. doi: 10.1007/s00292-009-1133-4.